COVID-19 Vaccine Development Tools Market Size Report, Industry Share, Analysis, Growth, Forecast,2032
COVID-19 Vaccine Development Tools Market - By Technology (Lab Technologies, PCR & qPCR, Flow Cytometry, Spectrometry, Electron Microscopy, and Next Generation Sequencing), By End-Use (CROs and Pharma & BioPharma Firms), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 7.12 Billion | USD 15.46 Billion | 9% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. COVID-19 Vaccine Development Touls Market, 2018–2028(USD Billion)
- 2.2. COVID-19 Vaccine Development Touls Market: Snapshot
- Chapter 3. Global COVID-19 Vaccine Development Touls Market– End-Use Analysis
- 3.1. COVID-19 Vaccine Development Touls Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Large-scale investment in research & development activities by private & government organizations for developing effective vaccines against COVID-19 will steer market trends.
- 3.2.2. Humungous utility of AI touls in development of COVID-19 vaccine and surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance expansion of COVID-19 vaccine development touls market in near future.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Technology
- 3.4.2. Market attractiveness analysis By End-Use
- Chapter 4. Global COVID-19 Vaccine Development Touls Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global COVID-19 Vaccine Development Touls Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Technology launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global COVID-19 Vaccine Development Touls Market– Technology Analysis
- 5.1. Global COVID-19 Vaccine Development Touls Market overview: By Technology
- 5.1.1. Global COVID-19 Vaccine Development Touls Market share, By Technology, 2020 and 2028
- 5.2. Lab Technulogies
- 5.2.1. Global COVID-19 Vaccine Development Touls Market by Lab Technulogies, 2018–2028(USD Billion)
- 5.3. PCR & qPCR
- 5.3.1. Global COVID-19 Vaccine Development Touls Market by PCR & qPCR, 2018–2028(USD Billion)
- 5.4. Flow Cytometry
- 5.4.1. Global COVID-19 Vaccine Development Touls Market by PCR & qPCR, 2018–2028(USD Billion)
- 5.5. Spectrometry
- 5.5.1. Global COVID-19 Vaccine Development Touls Market by Spectrometry, 2018–2028(USD Billion)
- 5.6. Electron Microscopy
- 5.6.1. Global COVID-19 Vaccine Development Touls Market by Electron Microscopy, 2018–2028(USD Billion)
- 5.7. Next Generation Sequencing
- 5.7.1. Global COVID-19 Vaccine Development Touls Market by Next Generation Sequencing, 2018–2028(USD Billion)
- 5.1. Global COVID-19 Vaccine Development Touls Market overview: By Technology
- Chapter 6. Global COVID-19 Vaccine Development Touls Market– End-Use Analysis
- 6.1. Global COVID-19 Vaccine Development Touls Market overview: By End-Use
- 6.1.1. Global COVID-19 Vaccine Development Touls Market share, By End-Use, 2020 and 2028
- 6.2. CROs
- 6.2.1. Global COVID-19 Vaccine Development Touls Market by CROs , 2018–2028(USD Billion)
- 6.3. Pharma & BioPharma Firms
- 6.3.1. Global COVID-19 Vaccine Development Touls Market by Pharma & BioPharma Firms, 2018–2028(USD Billion)
- 6.1. Global COVID-19 Vaccine Development Touls Market overview: By End-Use
- Chapter 7. Company Profiles
- 7.1. Thermo Fisher Scientific, Inc.
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Technology Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Pfizer Inc.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Technology Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Celerion
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Technology Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Development
- 7.4. Sartorius AG
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Technology Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Development
- 7.5. Cule-Parmer Instrument Company, LLC
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Technology Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. STEMCELL Technulogies Inc.
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Technology Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Illumina, Inc.
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Technology Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. AB Sciex Private Limited
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Technology Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Agilent Technulogies
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Technology Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. Aurora Biomed Inc.
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Technology Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Eurofins Scientific
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Technology Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. PerkinElmer Inc.
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Technology Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Shimadzu Corporation
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Technology Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. Merck KgaA
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Technology Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. Qiagen N.V.
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Technology Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.16. Bio-Rad Laboratories, Inc.
- 7.16.1. Overview
- 7.16.2. Financials
- 7.16.3. Technology Portfolio
- 7.16.4. Business Strategy
- 7.16.5. Recent Development
- 7.17. Danaher Corporation
- 7.17.1. Overview
- 7.17.2. Financials
- 7.17.3. Technology Portfolio
- 7.17.4. Business Strategy
- 7.17.5. Recent Development
- 7.1. Thermo Fisher Scientific, Inc.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global COVID-19 Vaccine Development Tools Marketattractiveness, By Technology
6. Global COVID-19 Vaccine Development Tools Marketattractiveness, By End-Use
7. Global COVID-19 Vaccine Development Tools Marketshare by Technology ,2020 and 2028 (USD Billion)
8. Global COVID-19 Vaccine Development Tools Marketby Lab Technologies, 2018–2028(USD Billion)
9. Global COVID-19 Vaccine Development Tools Marketby PCR & qPCR, 2018–2028(USD Billion)
10. Global COVID-19 Vaccine Development Tools Marketby Flow Cytometry, 2018–2028(USD Billion)
11. Global COVID-19 Vaccine Development Tools Marketby Spectrometry, 2018–2028(USD Billion)
12. Global COVID-19 Vaccine Development Tools Marketby Electron Microscopy, 2018–2028(USD Billion)
13. Global COVID-19 Vaccine Development Tools Marketby Next Generation Sequencing, 2018–2028(USD Billion)
14. Global COVID-19 Vaccine Development Tools Marketshare by End-Use ,2020 and 2028 (USD Billion)
15. Global COVID-19 Vaccine Development Tools Marketby CROs , 2018–2028(USD Billion)
16. Global COVID-19 Vaccine Development Tools Marketby Pharma & BioPharma Firms, 2018–2028(USD Billion)
17. Global COVID-19 Vaccine Development Tools Marketshare, by Region, 2020 and 2028
18. North America COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
19. Europe COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
20. Asia Pacific COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
21. Latin America COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
22. The Middle East and Africa COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1. Global COVID-19 Vaccine Development Tools Market: snapshot
2. Drivers of the COVID-19 Vaccine Development Tools Market: impact analysis
3. North America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
4. North America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
5. The U.S. COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
6. The U.S. COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
7. Rest of North America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
8. Rest of North America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
9. Europe COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
10. Europe COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
11. UK COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
12. UK COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
13. France COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
14. France COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
15. Germany COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
16. Germany COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
17. Rest of Europe COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
18. Rest of Europe COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
19. Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
20. Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
21. China COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
22. China COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
23. Japan COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
24. Japan COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
25. India COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
26. India COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
27. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
28. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
29. Latin America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
30. Latin America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
31. Brazil COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
32. Brazil COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
33. Rest of Latin America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
34. Rest of Latin America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
35. The Middle East and Africa COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
36. The Middle East and Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
37. Saudi Arabia COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
38. Saudi Arabia COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
39. South Africa COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
40. South Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
Increase in number of vaccine producers in both emerging economies and developed countries will boost growth of COVID-19 vaccine development tools market in upcoming years. Large-scale use of AI tools in development of COVID-19 vaccine and surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance expansion of COVID-19 vaccine development tools industry in foreseeable future.
According to Zion market research report, the global COVID-19 Vaccine Development Tools market accrued earnings worth approximately $ 7.12 Billion in 2023 to $ 15.46 Billion by 2032, with CAGR of around 9% from 2024 to 2032
Asia Pacific will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is owing to prominent surge in vaccine development for COVID-19 in countries such as India, Israel, and China. Furthermore, determining of new COVID genome in initial stage through use of modern sequencing tools by researchers of sub-continent will expedite business landscape in Asia Pacific over ensuing years. Additionally, large-scale utilization of genome sequencing tools, viral structure examination tools, and immune response profiling systems for developing new vaccines against COVID-19 will steer regional industry trends.
The key market participants include Thermo Fisher Scientific, Inc., Pfizer Inc., Celerion, Sartorius AG, Cole-Parmer Instrument Company, LLC, STEMCELL Technologies Inc., Illumina, Inc., AB Sciex Private Limited, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck KgaA, Shimadzu Corporation, PerkinElmer Inc., Eurofins Scientific, and Aurora Biomed Inc.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed